India to Arab Countries: To make Pharma Export easier

India has urged Arab countries to make it easier to export pharmaceutical products to the region and asked them to tap Indian farms to secure food supplies, as it seeks to diversify the $160 billion trade basket with the Arab bloc beyond hydrocarbons.

Indian pharma products enjoy great credibility around the world, but we do not have the same kind of recognition in most of the Arab world, because the process through which medicines are brought into your countries are very elaborate and cumbersome at times,” said Ambassador Sanjay Bhattacharyya, Secretary (Arab, OIA & CPV), Ministry of External Affairs.

Mr. Bhattacharya said market access to Indian pharma goods could be an ‘early harvest’ idea ahead of the India-Arab Partnership forum scheduled in the first week of December, after a gap of five years.

 

“We should look for an early harvest here by looking at the USFDA and GMP [Good Manufacturing Practice]-approved drugs that can come in as a first step.

India is a large producer of generics, but we also go beyond that,” he said at a meeting hosted by FICCI with Ambassadors of several Arab countries on economic opportunities between India and the Arab nations.

India-Arab trade accounts for 20% of India’s overall trade, but is still concentrated in hydrocarbons, the secretary said, mooting agriculture, technology and tourism as potential areas for diversification.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March